BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
HIV infection
,
Hippocampus
,
Autoimmunity
,
Fluoxetine
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chemotherapies
Summary
General Info
Curated Studies
Most Correlated Studies
Pre-treatment samples of primary breast tumors compared to post-treatment surgical specimens
Response to adjuvant chemotherapy in ovarian carcinoma
Breast tumors naive of chemotherapy and radiation therapy
Breast tumor biopsies of chemotherapy treated patients
Resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
Explore Curated Studies Results
Literature
Most Relevant Literature
Drug treatment of COVID-19 infection.
Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspecti…
Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic …
Repurposing drugs as COVID-19 therapies: A toxicity evaluation.
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
Nutrition and Chemotherapy
Virtual Reality Application in Chemotherapy
"Cancersensor" Chemotherapy
Predicting Biomarker of Gastric Cancer Chemotherapy Response
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ